What is X4 Pharmaceuticals Inc's ROA in the first quarter of 2025?
X4 Pharmaceuticals Inc achieved a return on average assets (ROA) of
8.78 % in its first quarter of 2025 a new company high.
ROA has improved compared to -23.14% in the fourth quarter of 2024, due to net income growth.
However, within the
Healthcare sector 82 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2025 quarter, so far to
618, from total ROA ranking in the fourth quarter of 2024 at
3591.
What is ROA?
